Rhythm Pharmaceuticals Inc.

NASDAQ:RYTM   3:59:55 PM EDT
3.22
-0.03 (-0.92%)
Earnings Announcements

Rhythm Pharmaceuticals Reports First Quarter 2022 Results

Published: 05/03/2022 11:45 GMT
Rhythm Pharmaceuticals Inc. (RYTM) - Rhythm Pharmaceuticals Reports First Quarter 2022 Financial Results and Business Update.
Q1 Loss per Share $1.05.
Revenue is expected to be $2.64 Million
Adjusted EPS is expected to be -$1.05

Next Quarter Revenue Guidance is expected to be $4.37 Million
Next Quarter EPS Guidance is expected to be -$1.00

More details on our Analysts Page.